National Resh Corp Stock Price, News & Analysis

National Research Corporation reported strong Q2 2021 results, achieving a 17% revenue increase to $36.4 million and a 32% rise in operating income to $12.2 million. The total recurring contract value grew 5% to $149.8 million, driven by a 29% boost in Voice of the Customer offerings. The cash balance increased to $48.9 million. However, the effective tax rate rose to 25% from 10% in the previous year, impacting net income which reached $8.9 million, up from $7.7 million. The company focuses on organic growth and enhancing client relationships.

National Research Corporation (NASDAQ:NRC) declared a quarterly cash dividend of $0.12 per share, payable July 15, 2021. Shareholders on record by June 30, 2021 will receive this dividend. With over 40 years of experience, NRC remains a leading provider of analytics and insights aimed at enhancing human understanding.

NRC Health enhances its leadership with the appointment of Penny Wheeler, CEO of Allina Health, and Stephen Lockhart, former Chief Medical Officer of Sutter Health, to its Board of Directors, effective immediately. These seasoned executives bring extensive healthcare experience and a commitment to patient-centered care. CEO Michael Hays emphasized their potential to advance NRC Health's mission of 'Human Understanding' in healthcare. Wheeler and Lockhart expressed enthusiasm for contributing to NRC’s vision of personalized healthcare experiences, particularly for underserved communities.

National Research Corporation (NASDAQ: NRC) reported its Q1 2021 results, highlighting a 5% revenue increase to $35.5 million and a 7% rise in operating income to $12 million compared to Q1 2020. The company achieved a 19% growth in Voice of the Customer offerings and secured new clients such as Wake Forest Baptist Health. However, net income dropped to $9.2 million from $11.8 million year-over-year, leading to a decrease in diluted earnings per share from $0.46 to $0.36. Total operating expenses increased by 3% to $23.4 million, with notable rises in selling, general and administrative expenses.

National Research Corporation (NASDAQ:NRC) has declared a quarterly cash dividend of $0.12 per share, scheduled for payment on April 27, 2021. Shareholders of record as of the close of business on April 19, 2021 will be eligible to receive this dividend. This announcement highlights NRC's commitment to returning value to its investors, sustaining a tradition of over 40 years in providing analytics and insights aimed at improving human understanding.

NRC Health has released the 2021 Healthcare Consumer Trends Report: Pediatrics, analyzing data on pediatric healthcare consumers during the COVID-19 pandemic. The report highlights shifts in brand loyalty, telehealth adoption, and parental preferences in provider selection. Key findings include a 2.2% decline in pediatric brand preference, with quality being the main factor for provider choice among 52% of parents. Furthermore, 51% of parents utilized telehealth services, and 80% expressed interest in discussions about wearable tech data with healthcare providers.

National Research Corporation (NASDAQ:NRC) announced its Q4 and year-end 2020 results. Q4 revenue rose 7% to $34.8 million, while operating income fell 15% to $10.2 million. Notably, net new sales dropped to $4.6 million. For the full year, revenue increased 4% to $133.3 million, and net income grew 15% to $37.3 million. The Voice of the Customer (VoC) platform saw a 19% increase in recurring contract value to $116.4 million. However, increased operating expenses and a goodwill impairment in Canada affected profitability.